Funding for this research was provided by:
National Multiple Sclerosis Society (RG-1707-28401)
Received: 24 June 2019
Accepted: 26 September 2019
First Online: 27 December 2019
Ethics approval and consent to participate
: The UW Human Subjects Division approved the study protocol (STUDY0004422) on 8 May 2018. We will obtain informed consent from all participants we enroll in the trial. Any major protocol changes will be submitted to the UW Human Subjects Division for approval; approved changes will be documented and communicated to study investigators, the Sponsor (National Multiple Sclerosis Society), and any other relevant parties. The trial registry will also be updated if indicated by such changes.
: Not applicable.
: The authors declare that they have no competing interests.